ALNOV.PA
Novacyt SA
Price:  
0.47 
EUR
Volume:  
37,382.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALNOV.PA EV/EBITDA

-519.7%
Upside

As of 2025-07-12, the EV/EBITDA ratio of Novacyt SA (ALNOV.PA) is -0.95. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALNOV.PA's latest enterprise value is 14.76 mil EUR. ALNOV.PA's TTM EBITDA according to its financial statements is -15.58 mil EUR. Dividing these 2 quantities gives us the above ALNOV.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.8x - 9.8x 8.7x
Forward P/E multiples 10.7x - 13.5x 11.6x
Fair Price (2.10) - (1.90) (1.98)
Upside -545.2% - -503.1% -519.7%
0.47 EUR
Stock Price
(1.98) EUR
Fair Price

ALNOV.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-10 -0.96
2025-07-09 -0.95
2025-07-08 -0.94
2025-07-07 -0.98
2025-07-04 -0.98
2025-07-03 -1.04
2025-07-02 -1.02
2025-07-01 -1.07
2025-06-30 -1.03
2025-06-27 -1.04
2025-06-26 -0.99
2025-06-25 -0.95
2025-06-24 -1.02
2025-06-23 -1.02
2025-06-20 -1.07
2025-06-19 -1.10
2025-06-18 -1.10
2025-06-17 -1.07
2025-06-16 -1.08
2025-06-13 -1.21
2025-06-12 -1.42
2025-06-11 -1.34
2025-06-10 -1.39
2025-06-09 -1.31
2025-06-06 -1.31
2025-06-05 -1.28
2025-06-04 -1.36
2025-06-03 -1.28
2025-06-02 -1.38
2025-05-30 -1.41
2025-05-29 -1.44
2025-05-28 -1.28
2025-05-27 -1.44
2025-05-26 -2.07
2025-05-23 -1.23
2025-05-22 -0.88
2025-05-21 -0.95
2025-05-20 -0.91
2025-05-19 -0.92
2025-05-16 -0.85
2025-05-15 -0.89
2025-05-14 -0.93
2025-05-13 -0.95
2025-05-12 -0.93
2025-05-09 -0.88
2025-05-08 -0.88
2025-05-07 -0.84
2025-05-06 -0.81
2025-05-05 -0.83
2025-05-02 -0.85